Namibia - English - Namibia Medicines Regulatory Council

resmed pharmaceuticals c.c - magnesium trisilicate, magnesium carbonate levis, sodium bicarbonate - suspension - each 5ml of suspension contains: magnesium trisilicate 250mg, magnesium carbonate levis 250mg, sodium bicarbonate 250mg

United States - English - NLM (National Library of Medicine)

rubimed ag - magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), sus scrofa pituitary gland (unii: e8s87o660t) (sus scrofa pituitary gland - unii:e8s87o660t) - magnesium carbonate 800 [hp_c] in 1 ml - homeopathic preparation for general well-being: lack of courage

Israel - English - Ministry of Health

inovamed ltd - magnesium sulfate as heptahydrate - solution for injection / concentrate for solution for inj/inf - magnesium sulfate as heptahydrate 500 mg / 1 ml - magnesium sulfate - magnesium sulfate 50%w/v inovamed is indicated for:1. the treatment of magnesium deficiency in hypomagnesaemia. 2. the prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutrition. 3. the control and prevention of seizures in severe pre-eclampsia. 4. the control and prevention of recurrent seizures in eclampsia

Israel - English - Ministry of Health

a.l. medi-market ltd. - magnesium sulfate heptahydrate - solution for injection / concentrate for solution for inj/inf - magnesium sulfate heptahydrate 500 mg / 1 ml - magnesium sulfate - magnesium sulfate kalceks 50% solution for injection or infusion is indicated for: the treatment of magnesium deficiency in hypomagnesaemiathe prevention and treatment of hypomagnesaemia in patients receiving total parenteral nutritionthe control and prevention of seizures in severe pre-eclampsiathe control and prevention of recurrent seizures in eclampsia

United States - English - NLM (National Library of Medicine)

seroyal usa - magnesium carbonate (unii: 0e53j927na) (carbonate ion - unii:7ujq5ope7d) - magnesium carbonate 1 [hp_x] - indications for the temporary relief of fatigue and constipation indications for the temporary relief of fatigue and constipation directions adults: take five granules three times daily or as recommended by your healthcare practitioner. children: take three granules and follow adult directions.

United States - English - NLM (National Library of Medicine)

santarus, inc. - omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9), sodium bicarbonate (unii: 8mdf5v39qo) (sodium bicarbonate - unii:8mdf5v39qo), magnesium hydroxide (unii: nbz3qy004s) (magnesium hydroxide - unii:nbz3qy004s) - tablet, chewable - 20 mg - zegerid with magnesium hydroxide is indicated for short-term treatment of active duodenal ulcer. most patients heal within four weeks. some patients may require an additional four weeks of therapy. zegerid with magnesium hydroxide is indicated for short-term treatment (4-8 weeks) of active benign gastric ulcer. (see clinical pharmacology, clinical studies, gastric ulcer.) zegerid with magnesium hydroxide is indicated for the treatment of heartburn and other symptoms associated with gerd. zegerid with magnesium hydroxide is indicated for the short-term treatment (4-8 weeks) of erosive esophagitis which has been diagnosed by endoscopy. (see clinical pharmacology, clinical studies.) the efficacy of zegerid with magnesium hydroxide used for longer than 8 weeks in these patients has not been established. in the rare instance of a patient not responding to 8 weeks of treatment, it may be helpful to give up to an additional 4 weeks of treatment. if there is recurrence of erosive esophagitis or gerd symptoms (eg, hea

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - magnesium sulfate heptahydrate, quantity: 500 mg/ml - injection, concentrated - excipient ingredients: water for injections - parenteral administration of magnesium is indicated in the treatment of acute hypomagnesaemia. magnesium salts are also indicated to prevent hypomagnesaemia in patients receiving total parenteral nutrition. magnesium sulphate is also indicated in the prevention and treatment of life-threatening seizures in the treatment of toxemias of pregnancy (pre-eclampsia and eclampsia). for emegency treatment of some arrhythmias such as torsade de pointes and those associated with hypokalemia.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for injection 10ml ampoules (martindale pharmaceuticals ltd - magnesium sulfate heptahydrate - solution for injection - 500mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for injection 20ml vials (torbay pharmaceuticals - magnesium sulfate heptahydrate - solution for injection - 500mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 2mmol/ml) solution for infusion 50ml vials (torbay pharmaceuticals - magnesium sulfate heptahydrate - solution for infusion - 500mg/1ml